The expansion of the worldwide central fill pharmacy automation market is anticipated to be driven by the increased demand for specialty medicine dispensing from central fill pharmacies. Speciality drugs have revolutionised medicine during the past two decades, extending the life expectancy and enhancing the quality of life for many people with chronic illnesses. As long as the medication can be obtained from a manufacturer or through an approved wholesale distribution channel, any registered pharmacy may dispense a speciality drug. The supply of generic pharmaceuticals, which are in high demand, has expanded in the global pharmaceutical industry as a result of increasing investments from pharmaceutical stakeholders and increased efficiency. In the end, this has helped fuel a global need for central fill pharmacy automation.
Over the projected period (2022-2030), the global Central Fill Pharmacy Automation Market is anticipated to grow at a CAGR of 12.2%, reaching an estimated market value of US$ 416.06 Mn in 2022.
Key Manufacturers in the Central Fill Pharmacy Automation Industry:
Omnicell:
1. For healthcare providers, Omnicell Inc. offers business analytics and automation software. Medication dispensing systems, pharmacy inventory management systems, and related software are all produced under the automation and analytics section. Founded 1992. Headquarter of the United States. Marketouch Media (Jan 2022), ReCept Pharmacy (Dec 2021), and Fdsamplicare.vdtrxn (Sep 2021) are the most recent acquisitions.
ARxIUM:
2. Automated services for the hospital pharmacy were designed and developed. By mechanically preparing IV syringes and bags, the company's Robotic Automation (RIVA) system answers concerns about patient and pharmacy technician safety, pharmacy efficiency and effectiveness, and the difficulties of a dynamic regulatory environment. Created in 2004. HQ for Canada. Google Purchases MicroLED Start-Up Raxium to Advance AR Goals
